A sample contract drafting and review checklist for a company's Procurement Services to use as a review tool / contract playbook, to aid in protecting the company's interests in contractual matters.
This research report discusses ways companies can optimize contract lifecycle management technology.
This article focuses on how to treat intellectual property (“IP”) and rights to IP in U.S. M&A transactions, particularly in the technology and life sciences sectors, in which IP often accounts for a substantial amount of Target’s value in the deal.
As we settle into the second half of the third year of the COVID-19 pandemic, there is reason for optimism. But, unfortunately, the outbreak of COVID-19- related litigation is still in its infancy.
COVID-19-related class action filings persist, largely in the form of wage and hour claims. Pandemic-induced layoffs have prompted lawsuits under the Worker Adjustment and Retraining Notification (WARN) Act. Negligence lawsuits have been filed by employees alleging to have contracted COVID-19 at the workplace or contending a family member fell ill because the employee brought the virus home from work.
The United States is in the midst of a unique cultural moment. A post-pandemic economy, a fractured political climate, a newly aggressive regulatory state, a deeply conservative U.S. Supreme Court and the relentless advance of technology have profoundly impacted our workplaces. This article looks at some of the class and collective actions at this historic juncture.
This article focuses on Public M&A, in which Target is a public reporting company under the Exchange Act.
This resource from Foley and Lardner provides insight into the most prominent trends throughout 2023. These trends are focused on the health care and life sciences sector.